Jim Cramer's top 10 things to watch in the stock market Tuesday

Intel is increasing its secondary stock sale size to $20B at $95 per share after the prior $15B plan was oversubscribed.

Choppy to slightly negative around execution, with upside possible if investors focus on foundry demand confidence.

The article discloses a concrete capital-raise change (size and price) but provides no new fundamentals beyond management confidence.

Nvidia’s $500B AI financing initiative is discussed, including participation by major Wall Street firms and Jensen Huang’s infrastructure framing.

Likely supportive bias for the stock, but with volatility from debate over financing economics.

The piece is largely commentary, but it includes specific initiative scale and named participants, which can move sentiment.

Riot Platforms surges after agreeing to a $9B compute deal with Anthropic to meet AI compute needs.

Near-term positive momentum likely, with follow-through depending on deal economics and execution.

The article states a specific $9B compute agreement and ties it to a same-day surge.

UBS upgraded Jabil to buy from hold, citing a multiyear growth cycle with AI-driven server rack demand and healthcare acceleration.

Moderately positive bias, especially if the market agrees with the multiyear cycle framing.

This is analyst-driven (not a company disclosure), but it includes a concrete upgrade and thesis.

Cardinal Health reports a big earnings beat, strong initial EPS guidance for fiscal 2027, and shares trade near an all-time high.

Supportive near-term trend, with upside if investors focus on guidance strength over revenue softness.

The article provides qualitative results and guidance direction but no numeric figures.

Jefferies’ sell call on Apple’s rumored all-glass iPhone being canceled is challenged by Bloomberg reporting the device remains on track for 2027.

Potential relief bounce, but likely capped until clearer confirmation emerges.

The article is about analyst positioning and media rumor confirmation, not a primary Apple disclosure.

Citi downgraded Allstate to sell from hold but raised its price target to $240, arguing the stock is significantly over-earning.

Volatile, with direction depending on whether traders weight the downgrade or the PT increase.

The article includes both downgrade and PT change, but no new company-specific operational data.